Crizotinib therapy for congenital embryonal rhabdomyosarcoma associated with an ATIC-ALK gene fusion.

Autor:	Akane Y; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan., Yamamoto M; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan., Takebayashi A; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan., Hamada R; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan., Igarashi K; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan., Emori M; Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan., Sugita S; Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan., Takada K; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan., Hasegawa T; Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan., Tsugawa T; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Jazyk:	angličtina
Zdroj:	Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31148. Date of Electronic Publication: 2024 Jun 17.
DOI:	10.1002/pbc.31148
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text